150 related articles for article (PubMed ID: 1693502)
21. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
Itoh H; Hidaka H
J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin.
Orallo F; Alvarez E; Basaran H; Lugnier C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):452-63. PubMed ID: 15599707
[TBL] [Abstract][Full Text] [Related]
23. A new peptide (1150Da) selectively activates the calcium-calmodulin sensitive isoform of cyclic nucleotide phosphodiesterase from human myometrium.
Leroy MJ; Dumler I; Lugnier C; Shushakova ND; Ferré F
Biochem Biophys Res Commun; 1992 Apr; 184(2):700-5. PubMed ID: 1315529
[TBL] [Abstract][Full Text] [Related]
24. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle.
Hagiwara M; Endo T; Hidaka H
Biochem Pharmacol; 1984 Feb; 33(3):453-7. PubMed ID: 6322804
[TBL] [Abstract][Full Text] [Related]
25. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase.
Hu ZY; Chen SL; Hao ZG; Huang WL; Peng SX
Cell Signal; 1989; 1(2):181-5. PubMed ID: 2561985
[TBL] [Abstract][Full Text] [Related]
26. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin.
Schaeffer P; Luginer C; Follenius-Wund A; Gerard D; Stoclet JC
Biochem Pharmacol; 1987 Jun; 36(12):1989-96. PubMed ID: 3036157
[TBL] [Abstract][Full Text] [Related]
28. SCH 45752--an inhibitor of calmodulin-sensitive cyclic nucleotide phosphodiesterase activity.
Hegde VR; Miller JR; Patel MG; King AH; Puar MS; Horan A; Hart R; Yarborough R; Gullo V
J Antibiot (Tokyo); 1993 Feb; 46(2):207-13. PubMed ID: 8385657
[TBL] [Abstract][Full Text] [Related]
29. Full activation without calmodulin of calmodulin-dependent cyclic nucleotide phosphodiesterase by acidic glycosphingolipids: GM3, sialosylneolactotetraosylceramide and sulfatide.
Higashi H; Yamagata T
FEBS Lett; 1992 Dec; 314(1):53-7. PubMed ID: 1333416
[TBL] [Abstract][Full Text] [Related]
30. Ruthenium red inhibits the binding of calcium to calmodulin required for enzyme activation.
Sasaki T; Naka M; Nakamura F; Tanaka T
J Biol Chem; 1992 Oct; 267(30):21518-23. PubMed ID: 1383224
[TBL] [Abstract][Full Text] [Related]
31. [Modulation of brain Ca2+-calmodulin-dependent phosphodiesterase activity by naphthalene sulfamides].
Shaĭkhin SM; Muratova MV; Belov AA; Khropov IuV; Kulagin SV
Biokhimiia; 1988 Aug; 53(8):1357-64. PubMed ID: 2847819
[TBL] [Abstract][Full Text] [Related]
32. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
[TBL] [Abstract][Full Text] [Related]
33. Inotropic responses to cyclic nucleotide phosphodiesterase inhibitors in immature and adult rabbit myocardium.
Artman M; Kithas PA; Wike JS; Crump DB; Strada SJ
J Cardiovasc Pharmacol; 1989 Jan; 13(1):146-54. PubMed ID: 2468926
[TBL] [Abstract][Full Text] [Related]
34. Activation of a cyclic nucleotide phosphodiesterase and of a protein kinase by chemically modified calmodulin.
Tertrin-Clary C; Chenut MC; de la Llosa P
Int J Biochem; 1987; 19(10):949-55. PubMed ID: 2822504
[TBL] [Abstract][Full Text] [Related]
35. Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.
Nicholson CD; Shahid M; Bruin J; Barron E; Spiers I; de Boer J; van Amsterdam RG; Zaagsma J; Kelly JJ; Dent G
J Pharmacol Exp Ther; 1995 Aug; 274(2):678-87. PubMed ID: 7636728
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
Dent G; Giembycz MA; Rabe KF; Barnes PJ
Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
[TBL] [Abstract][Full Text] [Related]
37. Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cells.
Watz MA; Holt IL; Howlett AC
J Neurosci Res; 1987; 17(3):291-7. PubMed ID: 3037096
[TBL] [Abstract][Full Text] [Related]
38. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate.
von Bülow V; Rink L; Haase H
J Immunol; 2005 Oct; 175(7):4697-705. PubMed ID: 16177117
[TBL] [Abstract][Full Text] [Related]
39. Influence of ruthenium red on rat heart subcellular calcium transport.
Gupta MP; Dixon IM; Zhao D; Dhalla NS
Can J Cardiol; 1989; 5(1):55-63. PubMed ID: 2465813
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of cyclic nucleotide phosphodiesterase and calmodulin in the small intestinal mucosa of rabbits].
Iurkov VA
Biull Eksp Biol Med; 1981 Jul; 92(7):91-4. PubMed ID: 6271290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
